OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
November 21, 2024
Located in German, Italy, and Lithuania, the new European facilities will specialize in drug discovery and R&D services.
November 20, 2024
SEKISUI has used a £15.7 million (US$20.7 million) investment to expand its clinical-grade drug substance manufacturing at its UK site.
November 12, 2024
Ascend is partnering with EW Healthcare Partners to expand capabilities in the United States.
November 04, 2024
The complexities of tech transfer may be overcome by data-driven approaches, digital tools, and effective communication.
October 30, 2024
The company will be expanding its quality control testing capabilities at its San Diego, Calif. biologics development and manufacturing site.
October 29, 2024
Marianna Tcherpakov, PhD, director of Business Development, CMC Services, at Frontage Laboratories, spoke on the CDMO’s role in tackling complex technical challenges to enable startup biotechs solve scale up problems.
October 28, 2024
Emerging therapies, patient-centric medicines, and the ever-changing world of bio/pharmaceuticals complicate technology transfer.
October 25, 2024
Pharmaceutical Technology Europe chats with Kevin Li, MBA, from BioDuro-Sundia about integrated services and the benefits these services can provide to pharma companies.
October 18, 2024
Cell and gene therapy experts Fabian Gerlinghaus, Dr. Claudia Zylberberg, and Benjamin McLeod weigh in on hot topics in CGT.